
Rednix Pharma Private Limited
About Rednix Pharma Private Limited
Data last updated:
Rednix Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 30 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2019PTC078197. Its GSTIN is 06AAJCR3912J1ZA (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandeep Kumar and Ashwani Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 1 Chaudhary Complex Relly Sector 12A, Panchkula, Haryana, India – 134109.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.4 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹89,371 (net margin 3%) and EBITDA of ₹1.57 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rednix Pharma Private Limited's registered office is in Panchkula, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 1 Chaudhary Complex Relly Sector 12A, Panchkula, Haryana, India – 134109
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Rednix Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rednix Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rednix Pharma Private Limited, buy the company report.
Financials of Rednix Pharma Private Limited
FY 2025 filings availableRednix Pharma Private Limited reported revenue of ₹29.4 Lakh (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over three years, including 1% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹89,371 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rednix Pharma Private Limited, buy the company report.
Board of directors of Rednix Pharma Private Limited
Rednix Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar | Director | 30 Jan 2019 | 7 Years 9 Months | Current |
| Ashwani Sharma | Director | 04 Mar 2019 | 7 Years 7 Months | Current |
| Taranvir Singh | Director | 04 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Rednix Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Davideson Medipharma Private Limited | ₹29.41 Lakh (FY 2024) | 3.0% | Deoria, Uttar Pradesh, India | |||
| Glorisa Technovation India Private Limited | ₹29.41 Lakh (FY 2025) | -17.0% | Ghaziabad, Uttar Pradesh, India | |||
| Octaglo Laboratories Private Limited | ₹29.41 Lakh (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Sar Multicomm Private Limited | ₹29.41 Lakh (FY 2024) | 9.0% | New Delhi, Delhi, India | |||
| Vanam Imports and Exports Private Limited | ₹29.4 Lakh (FY 2025) | -36.0% | Madanapalle, Andhra Pradesh, India | |||
| Rednix Pharma Private Limitedthis company | ₹29.4 Lakh (FY 2024) | ₹89,371 | 3% | 1.0% | Panchkula, Haryana, India | |
| Zanelini Apparel Private Limited | ₹29.4 Lakh (FY 2015) | 47.0% | New Delhi, Delhi, India | |||
| Btree Industries Private Limited | ₹29.4 Lakh (FY 2022) | 314.0% | Jaipur, Rajasthan, India | |||
| Shresha Museum Solutions Private Limited | ₹29.4 Lakh (FY 2025) | -82.0% | Thane, Maharashtra, India | |||
| CSD Sansar Infratec Cement Limited | ₹29.39 Lakh (FY 2016) | -85.0% | New Delhi, Delhi, India | |||
| Unicorn Beauty Private Limited | ₹29.39 Lakh (FY 2025) | -69.0% | Delhi, India |
To see the full peer comparison of Rednix Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rednix Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rednix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rednix Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAJCR3912J1ZA | Haryana | Active | 27 Mar 2019 |
To see the full GST registrations and return filing status of Rednix Pharma Private Limited, buy the company report.
Recent activity
Rednix Pharma Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Ashwani Sharma ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Rednix Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 30 January 2019 (7+ years old) and is registered under CIN U74999HR2019PTC078197.
Rednix Pharma has 3 current directors:
- Sandeep Kumar - Director
- Ashwani Sharma - Director
- Taranvir Singh - Director
The latest financial statements of Rednix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rednix Pharma is 06AAJCR3912J1ZA, registered in Haryana.
The CIN (Corporate Identification Number) of Rednix Pharma is U74999HR2019PTC078197. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rednix Pharma was incorporated on 30 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rednix Pharma by revenue are Davideson Medipharma Private Limited, Glorisa Technovation India Private Limited, Octaglo Laboratories Private Limited, Sar Multicomm Private Limited, Vanam Imports and Exports Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ashwani Sharma ceased to be Additional Director on 30 Sep 2019. Taranvir Singh ceased to be Additional Director on 30 Sep 2019. Taranvir Singh was appointed as Director on 04 Jun 2019. Rednix Pharma has 6 board changes on record in total.
The registered office of Rednix Pharma is at Shop No. 1 Chaudhary Complex Relly Sector 12A, Panchkula, Haryana, India – 134109.
Rednix Pharma operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Rednix Pharma is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.

